Results 261 to 270 of about 401,541 (313)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Multi-View Biomedical Foundation Models for Molecule-Target and Property Prediction. [PDF]

open access: yesAdv Sci (Weinh)
Suryanarayanan P   +17 more
europepmc   +1 more source

Harness Behavioural Analysis for Unpacking the Bio-Interpretability of Pathology Foundation Models

open access: yes
Hu Y   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy